Impact of coronary collateralization on major adverse cardiovascular and cerebrovascular events after successful recanalization of chronic total occlusion
Frontiers in Cardiovascular Medicine · 25.06.2024 · 11
DOI: 10.3389/fcvm.2024.1374398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 25.06.2024. Verfasst von Yurong Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Dalian Medical University, Dalian, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
This study aims to investigate the effects of coronary collateral circulation (CCC) on the prognosis of chronic total occlusion (CTO) patients with or without metabolic syndrome (MetS).
Methods
The study included 342 CTO patients who underwent successful percutaneous coronary intervention at the People's Hospital of Liaoning Province between 1 February 2021 and 30 September 2023. The Rentrop score was used to assess the status of CCC. The outcome was major adverse cardiovascular and cerebrovascular events (MACCEs), defined as a composite of all-cause mortality, cardiac death, non-fatal myocardial infarction (MI), target vessel revascularization (TVR), and non-fatal stroke. Univariate and multivariate logistic analyses were used to investigate the association of CCC, MetS, and MACCEs with odds ratios (ORs) and 95% confidence intervals (CIs). The effect of CCC was further investigated in different MetS, diabetes mellitus (DM), and Syntax score groups.
Results
MACCEs were more common in patients with poor CCC compared to those with good CCC (38.74% vs. 16.56%). Statistical differences were found in MACCEs (OR = 3.33, 95% CI: 1.93–5.72), MI (OR = 3.11, 95% CI: 1.73–5.58), TVR (OR = 3.06, 95% CI: 1.70–5.53), and stent thrombosis (OR = 6.14, 95% CI: 2.76–13.65) between the good and poor CCC groups. Poor CCC patients with MetS had a higher incidence of MACCEs (OR = 4.21, 95% CI: 2.05–8.65), non-fatal MI (OR = 4.44, 95% CI: 2.01–9.83), TVR (OR = 3.28, 95% CI: 1.51–7.11), and stent thrombosis (OR = 10.80, 95% CI: 3.11–37.54). Similar findings were also observed in CTO patients with DM and a Syntax score ≥23.
Conclusion
Poor CCC could increase the risk of MACCEs in CTO patients, particularly those with MetS, DM, and a Syntax score ≥23. Further prospective, multicenter studies are needed to validate our findings and to explore potential therapeutic interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, Dalian Medical University, Dalian, China.
- Department of Cardiology, People's Hospital of Liaoning Province, The People's Hospital of China Medical University, Shenyang, Liaoning, China.
- Clinical Medicine, China Medical University, Shenyang, Liaoning, China.
Zitieren
APA
Sun, Y., Zhang, B., Zhang, X., Zhang, X., Bao, W., Bai, H., & Luan, B. (2024). Impact of coronary collateralization on major adverse cardiovascular and cerebrovascular events after successful recanalization of chronic total occlusion. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1374398
Vancouver
Sun Y, Zhang B, Zhang X, Zhang X, Bao W, Bai H, et al. Impact of coronary collateralization on major adverse cardiovascular and cerebrovascular events after successful recanalization of chronic total occlusion. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1374398
BibTeX
@article{Sun2024,
author = {Sun, Yurong and Zhang, Bin and Zhang, Xinyuan and Zhang, Xiaojiao and Bao, Wenqi and Bai, Hangrui and Luan, Bo},
title = {Impact of coronary collateralization on major adverse cardiovascular and cerebrovascular events after successful recanalization of chronic total occlusion},
journal = {Frontiers in Cardiovascular Medicine},
year = {2024},
volume = {11},
doi = {10.3389/fcvm.2024.1374398}
}
EUVIMED